WO2025011610 - AMIDE DERIVATIVE, AND COMPOSITION AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/011610
Publication Date
16.01.2025
International Application No.
PCT/CN2024/104905
International Filing Date
11.07.2024
Title **
[English]
AMIDE DERIVATIVE, AND COMPOSITION AND USE THEREOF
[French]
DÉRIVÉ D'AMIDE, COMPOSITION ET UTILISATION ASSOCIÉES
[Chinese]
酰胺衍生物及其组合物及用途
Applicants **
SHENZHEN TARGETRX, INC.
Inventors
WANG, Yihan
LI, Huanyin
Priority Data
202310863831.0
13.07.2023
CN
202410445275.X
12.04.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4139 | |
| EPO | Filing, Examination, Granting | 33378 | |
| Japan | Filing, Examination, Granting | 3135 | |
| South Korea | Filing, Examination, Granting | 4188 | |
| USA | Filing, Examination, Granting | 11290 |
Total:
56,130
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to an amide derivative, and a composition and use thereof, the amide derivative being a compound of formula (I), or a tautomer, stereoisomer, prodrug, crystal form, pharmaceutically acceptable salt, hydrate or solvate thereof, a pharmaceutical composition thereof, and a use thereof in the treatment and/or prevention of viral infections.[French]
La présente invention concerne un dérivé d'amide, une composition et son utilisation, le dérivé d'amide étant un composé de formule (I), ou un tautomère, un stéréoisomère, un promédicament, une forme cristalline, un sel, hydrate ou solvate pharmaceutiquement acceptable de celui-ci, une composition pharmaceutique de celui-ci, et une utilisation de ceux-ci dans le traitement et/ou la prévention d'infections virales.[Chinese]
涉及一种酰胺衍生物及其组合物及其用途，所述酰胺衍生物为式(Ⅰ)的化合物，或其互变异构体、立体异构体、前药、晶型、药学上可接受的盐、水合物或溶剂合物，及其药物组合物和它们在治疗和/或预防病毒感染中的用途。